[Effect of brentuximab vedotin combined with chlormethine hydrochloride on the treatment of 6 patients with relapsed and refractory Hodgkin lymphoma].

Cao, Zhigang; Wang, Zhihong; Sun, Junzhong; Peng, Chaojin; Feng, Shaomei; Zhou, Xiaoyan; Yang, Qingming

Cao, Zhigang; Wang, Zhihong; Sun, Junzhong; Peng, Chaojin; Feng, Shaomei; Zhou, Xiaoyan; Yang, Qingming.

Afiliação

Cao Z; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Wang Z; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Sun J; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Peng C; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Feng S; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Zhou X; The General Hospital of People's Liberation Armyl, Beijing 100853, China.
Yang Q; The General Hospital of People's Liberation Armyl, Beijing 100853, China.

Zhonghua Xue Ye Xue Za Zhi ; 36(7): 575-7, 2015 Jul.

Article em Zh | MEDLINE | ID: mdl-26304081

Assuntos

Doença de Hodgkin/tratamento farmacológico; Imunoconjugados/uso terapêutico; Mecloretamina/uso terapêutico; Antineoplásicos Alquilantes/uso terapêutico; Brentuximab Vedotin; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados / Mecloretamina Limite: Humans Idioma: Zh Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google